ABDX Insider Trading

Insider Ownership Percentage: 56.05%
Insider Buying (Last 12 Months): £10,000
Insider Selling (Last 12 Months): GBX 0

Abingdon Health Insider Trading History Chart

This chart shows the insider buying and selling history at Abingdon Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Abingdon Health Share Price & Price History

Current Price: GBX 10.85
Price Change: Price Decrease of -0.155 (-1.41%)
As of 05/17/2024 05:10 PM ET

This chart shows the closing price history over time for ABDX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Abingdon Health Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/24/2023Christopher HandInsiderBuy100,000GBX 10£10,000
9/23/2022Chris Henry Francis YatesInsiderBuy125,000GBX 7£8,750
9/15/2022Chris Henry Francis YatesInsiderBuy50,000GBX 627£313,500
See Full Table

SEC Filings (Institutional Ownership Changes) for Abingdon Health (LON:ABDX)

10.58% of Abingdon Health stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Abingdon Health logo
Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides Abingdon Simply Test, a range of self-tests in the field of fertility, health and well-being, infectious diseases, and drug testing; PCRD and PCRD FLEX, are nucleic acid lateral flow tests, which are used for rapid readouts post isothermal amplification; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2, as well as plant health tests; and nucleic acid lateral flow immunoassays. It also offers AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader; and Salistick, a rapid saliva-based pregnancy test. In addition, the company provides contract manufacturing, nucleic acid lateral flow test customization, and lateral flow development and manufacturing services. Further, it offers regulatory consultancy services for businesses in the diagnostics sector. The company has a strategic collaboration with DeepVerge plc for the development, manufacturing, and commercialization of lateral flow tests; and Vatic Health Limited for the development, manufacturing, and commercialization of infectious disease lateral flow self-tests. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.
Read More on Abingdon Health

Today's Range

Now: GBX 10.85
Low: 10.50
High: 11.75

50 Day Range

MA: GBX 9.82
Low: 6.93
High: 11.50

52 Week Range

Now: GBX 10.85
Low: 6.50
High: 18.50

Volume

497,834 shs

Average Volume

319,570 shs

Market Capitalization

£13.74 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.09

Who are the company insiders with the largest holdings of Abingdon Health?

Abingdon Health's top insider investors include:
  1. Chris Henry Francis Yates (Insider)
  2. Christopher Hand (Insider)
Learn More about top insider investors at Abingdon Health.